PCG
RCPI

Private Capital Group’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Private Capital Group’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-420
Closed – – 2178
2020
Q2 		$0 Hold
420
– – ﹤0.01% 2215
2020
Q1 		$0 Hold
420
– – ﹤0.01% 2249
2019
Q4 		$0 Hold
420
– – ﹤0.01% 2327
2019
Q3 		$0 Hold
420
– – ﹤0.01% 2614
2019
Q2 		$0 Hold
420
– – ﹤0.01% 2530
2019
Q1 		$0 Hold
420
– – ﹤0.01% 2372
2018
Q4 		$0 Hold
420
– – ﹤0.01% 2443
2018
Q3 		$0 Hold
420
– – ﹤0.01% 2372
2018
Q2 		$0 Hold
420
– – ﹤0.01% 2354
2018
Q1 		$0 Hold
420
– – ﹤0.01% 2258
2017
Q4 		$0 Buy
+420
New – ﹤0.01% 2111

Private Capital Group's RCPI Position: Q3 2020 in Review

Private Capital Group sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2020, closing a stake of 420 shares.

Private Capital Group first reported a position in RCPI in Q4 2017 and held it in 11 quarters. The position peaked at $0 in Q2 2020. 0 funds tracked by Wall St. Rank hold RCPI as of Q3 2020.

  • Private Capital Group reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2020 after selling out during the quarter.
  • Private Capital Group sold 420 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2020.
  • Private Capital Group first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q4 2017 and held it in 11 quarters.
  • Private Capital Group's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $0 in Q2 2020.
  • 0 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2020.

Based on Private Capital Group's 13F filing for Q3 2020, filed 12 Nov 2020.